3 completed, 1 not yet recruiting, 1 terminated. 5 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 3, Not yet recruiting 1, Terminated 1 |
| Phase 3 | 1 | Terminated 1 |
Follow Sage Therapeutics: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pregnenolone to Target Concurrent PTSD and Stress Induced Alcohol Use in Veterans: A Dose Finding Study Brexanolone - Alcohol Use Disorder (AUD), Post Traumatic Stress Disorder (PTSD) | Phase 2 | Not yet recruiting | Pharmacotherapies for Alcohol and Substance Use Disorders Alliance | 40 | 2027-01-15 | 2026-09-21 |
| A Study to Evaluate the Long-term Safety and Tolerability of SAGE-324 in Participants With Essential Tremor SAGE-324 - Essential Tremor | Phase 2 / Phase 3 | Terminated | Sage Therapeutics | 97 | 2022-06-03 | 2025-08-01 |
| Study to Evaluate SAGE-324 in Participants With Essential Tremor SAGE-324, SAGE-324 Matched Placebo - Essential Tremor | Phase 2 | Completed | Sage Therapeutics | 146 | 2022-01-05 | 2025-05-16 |
| A Study to Evaluate the Efficacy, Safety, and Tolerability of SAGE-324 in Participants With Essential Tremor SAGE-324, SAGE-324 Placebo - Essential Tremor | Phase 2 | Completed | Sage Therapeutics | 69 | 2020-05-19 | 2024-04-17 |
| Evaluate SAGE-547 in Participants With Essential Tremor SAGE-547, Placebo - Essential Tremor | Phase 2 | Completed | Sage Therapeutics | 25 | 2014-09-23 | 2022-06-29 |
Essential Tremor (4) · Alcohol Drinking (1) · Alcoholism (1) · Stress Disorders, Post-Traumatic (1)
brexanolone (2)
United States (4)
MacKenzie R. Peltier, Ph.D. (1) · Robert Lasser, MD, MBA (1)